Clinical trial suggests hypertension self-management strategies may be effective to control blood pressure

FHS
May 16, 2024
3:10 pm

The study findings suggest that self-management strategies for hypertension may effectively reduce blood pressure levels over 24 months without increasing healthcare resource utilization or adverse events as compared to usual care.

Risk adjusted net present value: What is the current valuation of Eli Lilly and Co’s LY-3972406?

LY-3972406 is a small molecule commercialized by Eli Lilly and Co, with a leading Phase II program in Plaque Psoriasis (Psoriasis Vulgaris).

April 17, 2024

Personalized vitamin D guidelines based on latitude and skin type could tackle deficiencies

Study highlights the importance of personalized vitamin D exposure recommendations based on latitude, skin type, and seasonal variations, providing valuable insights for addressing widespread deficiencies.

May 17, 2024

Sanofi shelves four assets, including mid-stage dwarfism candidate

Sanofi is deprioritizing a mid-stage treatment for a form of dwarfism and culling three other early-stage studies. The French pharma deprioritized a Phase 2 drug

July 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.